Your browser doesn't support javascript.
loading
Pembrolizumab plus single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma.
Suzuki, Kenshi.
Affiliation
  • Suzuki K; Myeloma and AL Amyloidosis Unit, Japanese Red Cross Medical Center, Tokyo 150-8935, Japan. Electronic address: ken-suzuki@mtb.biglobe.ne.jp.
Lancet Haematol ; 11(7): e473-e475, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38937020
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Multiple Myeloma Limits: Humans Language: En Journal: Lancet Haematol Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Multiple Myeloma Limits: Humans Language: En Journal: Lancet Haematol Year: 2024 Document type: Article